The Practicality of Direct to Patient Shipments for Sites & Patients
Part 2 of a 2-Part Panel Series
This panel discussion focuses on the impact of Direct to Patient (DtP) medication shipments on patients and sites. How have they been affected by the increase in DtP shipments during the COVID-19 pandemic? And how can technology ease their burdens and support new shipping workflows?
Dr. Jeffrey B. Rosen
Dr. Jeffrey B. Rosen is a board-certified Family Medicine doctor in Coral Gables, Florida and is affiliated with multiple hospitals in the area, including Baptist Health Baptist Hospital and Baptist Health South Miami Hospital. He received his medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice for more than 39 years. He has been a national speaker on various therapeutics and vaccines and is very highly esteemed in the medical community.
Alongside his medical practice, Dr. Rosen has served as Principal Investigator on over 800 clinical trials, in every phase of development and virtually all therapeutic areas. He also serves as Chief Medical Officer for the Alliance for Multispecialty Research. This organization, and Dr. Rosen personally, has played a pivotal role in the recent testing and approval of COVID-19 vaccinations and therapeutics, and they continue to make significant contributions to medicine and public health.
Co-Chair, Decentralized Trials & Research Alliance
Craig was the Head of Clinical Innovation and Venture Partner at Pfizer. During that time, he led the design and launch of multiple industry firsts -- from the first fully remote/virtual clinical trial for a new medicine to the first returning of results and data to research participants.
Mai Kay Jones
Specialist Senior Pharmacy Technician - Clinical Trials
Mai Kay Jones is the lead pharmacy technician for the pharmacy set-up and maintenance of early phase cancer studies. Ms. Jones has eight years of experience in this field, working closely with the research teams and sponsors to support the delivery of high-quality research and patient care.
Vice President, Scientific E-tech Enabled Services, Calyx
Craig Mooney has nearly 30 years’ experience in the clinical development industry, with concentrated focus on optimizing IRT to improve clinical trial efficiencies. Craig brings a unique understanding of IRT from both a delivery and user perspective, having served as the Director of IRT at Bristol-Myers Squibb for most of the past decade and having held roles in clinical operations, IMP packaging, and labeling & logistics. He is considered an industry expert and has been a featured speaker at numerous IRT conferences including positions as Conference Chairman.
Director, Solution Consultant, Calyx (Moderator)
Sylvain has acquired extensive experience in IRT through various roles within Calyx over his 10+ years in the company. It allows him to grasp where IRT can make a difference based on the protocol design, and accordingly advise clinical trial teams what solution is the most suitable for each trial. Sylvain is a key member of the Calyx IRT product core team, acting as an advocate for end-users, as well as sharing his vision with the team to push the boundaries of IRT.